Literatur
- 1
Greenblatt R B et al.
Induction of ovulation with MRL / 41. Preliminary report.
J Am Med Assoc.
1961;
178
101-104
- 2
Kerin J F et al.
Evidence for a hypothalamic site of action of clomiphene citrate in women.
J Clin Endocrinol Metab.
1985;
61
265-268
- 3
Nawroth F.
Anwendung von Clomifen zur ovariellen Stimulation.
Gynäkolog Endokrinol.
2007;
5
39-48
- 4
Thessaloniki ESHRE / ASRM-Sponsored PCOS Consensus Workshop Group .
Consensus on infertility treatment related to polycystic ovary syndrome.
Hum Reprod.
2008;
23
462-477
- 5 Verhulst S M et al. Intra-uterine insemination for unexplained subfertility. Cochrane
Database Syst Rev 2006 CD001838
- 6
Rostami-Hodjegan A et al.
Monitoring plasma concentrations to individualize treatment with clomiphene citrate.
Fertil Steril.
2004;
81
1187-1193
- 7
Wu C H, Winkel C A.
The effect of therapy initiation day on clomiphene citrate therapy.
Fertil Steril.
1989;
52
564-568
- 8
Farhi J, Orvieto R, Homburg R.
Administration of clomiphene citrate in patients with polycystic ovary syndrome, without
inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome.
Fertil Steril.
2010;
93
2077-2079
- 9 NICE. Fertility: Assessment and treatment for people with fertility problems. A
clinical guideline.. London: RCOG Press; 2004
- 10
Coughlan C et al.
Is it safe to prescribe clomiphene citrate without ultrasound monitoring facilities?.
J Obstet Gynaecol.
2010;
30
393-396
- 11
Navot D et al.
Multiple pregnancies: risk factors and prognostic variables during induction of ovulation
with human menopausal gonadotrophins.
Hum Reprod.
1991;
6
1152-1155
- 12
Wilcox A J, Weinberg C R, Baird D D.
Timing of sexual intercourse in relation to ovulation. Effects on the probability
of conception, survival of the pregnancy, and sex of the baby.
N Engl J Med.
1995;
333
1517-1521
- 13 George K, Nair R, Tharyan P. Ovulation triggers in anovulatory women undergoing
ovulation induction. Cochrane Database Syst Rev 2008 CD006900
- 14 Brown J et al. Clomiphene and anti-oestrogens for ovulation induction in PCOS. Cochrane
Database Syst Rev 2009 CD002249
- 15 Hughes E et al. Clomiphene citrate for unexplained subfertility in women. Cochrane
Database Syst Rev 2010 CD000057
- 16
Homburg R.
Clomiphene citrate – end of an era? A mini-review.
Hum Reprod.
2005;
20
2043-2051
- 17
Imani B et al.
A nomogram to predict the probability of live birth after clomiphene citrate induction
of ovulation in normogonadotropic oligoamenorrheic infertility.
Fertil Steril.
2002;
77
91-97
- 18
Kyrou D et al.
Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for
intrauterine insemination: need or habit?.
Hum Reprod.
2010;
25
2501-2506
- 19
Erdem A et al.
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles:
a prospective randomized study.
Fertil Steril.
2009;
91
2508-2513
- 20
Dickey R P.
The relative contribution of assisted reproductive technologies and ovulation induction
to multiple births in the United States 5 years after the Society for Assisted Reproductive
Technology/American Society for Reproductive Medicine recommendation to limit the
number of embryos transferred.
Fertil Steril.
2007;
88
1554-1561
- 21
Richter K S et al.
Relationship between endometrial thickness and embryo implantation, based on 1294 cycles
of in vitro fertilization with transfer of two blastocyst-stage embryos.
Fertil Steril.
2007;
87
53-59
- 22
Kolibianakis E M et al.
Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated
with clomiphene citrate for intrauterine insemination.
Reprod Biomed Online.
2004;
8
115-118
- 23
Gerli S et al.
Use of ethinyl estradiol to reverse the antiestrogenic effects of clomiphene citrate
in patients undergoing intrauterine insemination: a comparative, randomized study.
Fertil Steril.
2000;
73
85-89
- 24
Bromer J G, Aldad T S, Taylor H S.
Defining the proliferative phase endometrial defect.
Fertil Steril.
2009;
91
698-704
- 25
Vlahos N F, Economopoulos K P, Creatsas G.
Fertility drugs and ovarian cancer risk: a critical review of the literature.
Ann NY Acad Sci.
2010;
1205
214-219
- 26
Jensen A et al.
Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort
Study.
Brit Med J.
2009;
338
b249
- 27
Rossing M A et al.
Ovarian tumors in a cohort of infertile women.
N Engl J Med.
1994;
331
771-776
- 28
Palomba S, Falbo A, Zullo F.
Management strategies for ovulation induction in women with polycystic ovary syndrome
and known clomifene citrate resistance.
Curr Opin Obstet Gynecol.
2009;
21
465-473
- 29 Farquhar C et al. Laparoscopic “drilling” by diathermy or laser for ovulation induction
in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev 2005 CD001122
- 30
Ganesh A et al.
Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin
combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure:
a randomized prospective clinical trial.
J Assist Reprod Genet.
2009;
26
19-24
- 31 Tang T et al. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone,
D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and
subfertility. Cochrane Database Syst Rev 2010 CD003053
- 32
Johnson N P et al.
PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating
Metformin for Infertility with Clomiphene.
Hum Reprod.
2010;
25
1675-1683
- 33
Palomba S et al.
Six weeks of structured exercise training and hypocaloric diet increases the probability
of ovulation after clomiphene citrate in overweight and obese patients with polycystic
ovary syndrome: a randomized controlled trial.
Hum Reprod.
2010;
25
2783-2791
- 34
Begum K S, Sachchithanantham K, De Somsubhra S.
Maternal obesity and pregnancy outcome.
Clin Exp Obstet Gynecol.
2011;
38
14-20
- 35
Norman R J et al.
Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin
dependent diabetes mellitus in polycystic ovarian syndrome.
Hum Reprod.
2001;
16
1995-1998
- 36
He D, Jiang F.
Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome.
Reprod Biomed Online.
2011;
- 37
Abu Hashim H, Shokeir T, Badawy A.
Letrozole versus combined metformin and clomiphene citrate for ovulation induction
in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled
trial.
Fertil Steril.
2010;
94
1405-1409
- 38
Abdellah M S.
Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant
polycystic ovary syndrome.
Int J Gynaecol Obstet.
2011;
Priv.-Doz. Dr. med. B. Sonntag
Zentrum für Endokrinologie · Kinderwunsch · Pränatale Medizin · amedes Hamburg
Mönckebergstr. 10
20095 Hamburg
Email: barbara.sonntag@amedes-group.com
